“…Because SVMPs require a divalent cation such as zinc for activity, the use of metal chelating agents such as CaNa 2 EDTA( Flowers and Goucher, 1963 , 1965 ; Gowda et al, 2011 ; Howes et al, 2007 ; León et al, 1998 ; Rucavado et al, 2000 ; Silva-Neto et al, 2018 ), tetraethyl thiuram disulfide (Disulfiram/TTD)( Nanjaraj Urs et al, 2015 ; Rudresha et al, 2021 ), 2,3-dimercapto-1-propanesulfonic acid (DMPS/Unithiol)( Albulescu et al, 2020a ; Menzies et al, 2022 ; Xie et al, 2020a ), and dimercaprol (British anti-Lewisite) ( Albulescu et al, 2020b ; Xie et al, 2020b ) for SBE therapy has been demonstrated in a variety of animal models. These agents have traditionally been used to treat metal intoxication( Flora and Pachauri, 2010 ), but have found a use as repurposed drugs for SBE therapy.…”